GH Research Plc (GHRS)
28.09
-0.24
(-0.85%)
USD |
NASDAQ |
Aug 24, 16:00
28.09
0.00 (0.00%)
After-Hours: 20:00
GH Research Debt to Equity Ratio : 0.001 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.001 |
| March 31, 2026 | 0.0016 |
| December 31, 2025 | 0.0018 |
| September 30, 2025 | 0.002 |
| June 30, 2025 | 0.0021 |
| March 31, 2025 | 0.0021 |
| December 31, 2024 | 0.0035 |
| September 30, 2024 | 0.0039 |
| June 30, 2024 | 0.0038 |
| March 31, 2024 | 0.0043 |
| December 31, 2023 | 0.0044 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.0041 |
| June 30, 2023 | 0.0043 |
| March 31, 2023 | 0.0047 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Atai Beckley, Inc. | 0.0107 |
| Avadel Pharmaceuticals Plc | -- |
| Jazz Pharmaceuticals Plc | 0.9183 |
| Eli Lilly & Co. | 1.621 |
| Perrigo Co. Plc | 1.375 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 372.35M |
| Total Liabilities (Quarterly) | 12.86M |
| Shareholders Equity (Quarterly) | 359.49M |
| Current Ratio | 28.70 |
| Net Debt Paydown Yield | 0.00% |